8
SAHU ET AL.
ORCID
Sahu, N. U., Singh, V., Ferraris, D. M., Rizzi, M., & Kharkar, P. S. (2018). Hit
0
discovery of Mycobacterium tuberculosis inosine 5 -monophosphate
dehydrogenase, GuaB2, inhibitors. Bioorganic & Medicinal Chemistry
Letters, 28(10), 1714–1718.
Prashant S. Kharkar
Saiakhov, R., Chakravarti, S., & Klopman, G. (2013). Effectiveness of CASE
ultra expert system in evaluating adverse effects of drugs. Molecular
Informatics, 32(1), 87–97.
Saiakhov, R., Chakravarti, S., & Sedykh, A. (2014). An improved workflow
to perform in silico mutagenicity assessment of impurities as per ICH
M7 guideline. Toxicology Letters, 229(2014), S164.
REFERENCES
Cushnie, T. P. T., & Lamb, A. J. (2005). Antimicrobial activity of flavonoids.
International Journal of Antimicrobial Agents, 26(5), 343–356.
Dunkern, T., Chavan, S., Bankar, D., Patil, A., Kulkarni, P., Kharkar, P. S., …
Makhija, M. T. (2014). Design, synthesis and biological evaluation
0
Serafini, M., Peluso, I., & Raguzzini, A. (2010). Flavonoids as anti-inflammatory
agents. Proceedings of the Nutrition Society, 69(3), 273–278.
of novel inosine 5 -monophosphate dehydrogenase (IMPDH) inhibi-
tors. Journal of Enzyme Inhibition and Medicinal Chemistry, 29(3),
0
Shah, C. S., & Kharkar, P. (2015). Inosine 5 -monophosphate dehydroge-
4
08–419.
nase inhibitors as antimicrobial agents: Recent progress and future per-
Dunkern, T., Prabhu, A., Kharkar, P. S., Goebel, H., Rolser, E., Burckhard-
spectives. Future Medicinal Chemistry, 7(11), 1415–1429.
Shah, C. P., & Kharkar, P. S. (2018). Newer human inosine 5 -monophosphate
Boer, W., … Makhija, M. T. (2012). Virtual and experimental high-
throughput screening (HTS) in search of novel inosine 5 -monophosphate
0
0
dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
Journal of Enzyme Inhibition and Medicinal Chemistry, 33(1), 972–977.
Siddique, O., Ovalle, A., Siddique, A. S., & Moss, S. F. (2018). Helicobacter
pylori infection: An update for the internist in the age of increasing global
antibiotic resistance. American Journal of Medicine, 131(5), 473–479.
Singh, M., Kaur, M., & Silakari, O. (2014). Flavones: An important scaffold
for medicinal chemistry. European Journal of Medicinal Chemistry, 84,
dehydrogenase II (IMPDH II) inhibitors. Journal of Computer-Aided
Molecular Design, 26(11), 1277–1292.
Ezmin, A., Azlina, I., & Azilah, S. (2017). Papr reduction using scs-slm tech-
nique in stfbc mimo-ofdm. ARPN Journal of Engineering and Applied
Sciences, 12(10), 3218–3221.
Fernicola, S., Torquati, I., Paiardini, A., Giardina, G., Rampioni, G.,
Messina, M., … Cutruzzolá, F. (2015). Synthesis of triazole-linked ana-
logues of c-di-GMP and their interactions with diguanylate cyclase.
Journal of Medicinal Chemistry, 58(20), 8269–8284.
2
06–239.
Tharmalingam, N., Port, J., Castillo, D., & Mylonakis, E. (2018). Repurposing
the anthelmintic drug niclosamide to combat Helicobacter pylori. Scien-
tific Reports, 8(1), 1–12.
Fuccio, L., Laterza, L., Zagari, R. M., Cennamo, V., Grilli, D., & Bazzoli, F.
(
2008). Treatment of Helicobacter pylori infection. British Medical Jour-
Thung, I., Aramin, H., Vavinskaya, V., Gupta, S., Park, J. Y., Crowe, S. E., &
Valasek, M. A. (2016). Review article: The global emergence of Helico-
bacter pylori antibiotic resistance. Alimentary Pharmacology and Thera-
peutics, 43(4), 514–533.
nal, 337(7672), 746–750.
Gallus, J., Juvale, K., & Wiese, M. (2014). Characterization of 3-methoxy
flavones for their interaction with ABCG2 as suggested by ATPase
activity. Biochimica et Biophysica Acta—Biomembranes, 1838(11),
Vakil, N., & Vaira, D. (2013). Treatment for H. pylori infection new chal-
lenges with antimicrobial resistance. Journal of Clinical Gastroenterology,
2
929–2938.
Gollapalli, D. R., MacPherson, I. S., Liechti, G., Gorla, S. K.,
Goldberg, J. B., & Hedstrom, L. (2010). Structural determinants of
inhibitor selectivity in prokaryotic IMP dehydrogenases. Chemistry and
Biology, 17(10), 1084–1091.
Hedstrom, L. (2009). IMP dehydrogenase: Structure, mechanism, and inhi-
bition. Chemical Reviews, 109(7), 2903–2928.
Hedstrom, L., Liechti, G., Goldberg, J. B., & Gollapalli, D. R. (2011). The
antibiotic potential of prokaryotic IMP dehydrogenase inhibitors. Cur-
rent Medicinal Chemistry, 18(13), 1909–1918.
Isobe, T., Doe, M., Morimoto, Y., Nagata, K., & Ohsaki, A. (2006). The
anti-Helicobacter pylori flavones in a Brazilian plant, Hyptis fasciculata,
and the activity of methoxyflavones. Biological & Pharmaceutical Bulle-
tin, 29(5), 1039–1041.
4
7(5), 383–388.
Venkatachalam, H., Nayak, Y., & Jayashree, B. S. (2012). Synthesis, charac-
terization and antioxidant activities of synthetic chalcones and fla-
vones. APCBEE Procedia, 3, 209–213.
Wroblewski, L. E., Peek, R. M., & Wilson, K. T. (2010). Helicobacter pylori
and gastric cancer: Factors that modulate disease risk. Clinical Microbi-
ology Reviews, 23(4), 713–739.
Zagari, R. M., Rabitti, S., Eusebi, L. H., & Bazzoli, F. (2018). Treatment of
Helicobacter pylori infection: A clinical practice update. European Jour-
nal of Clinical Investigation, 48(1), e12857.
Zhang, R., Evans, G., Rotella, F. J., Westbrook, E. M., Beno, D.,
Huberman, E., … Collart, F. R. (1999). Characteristics and crystal struc-
0
ture of bacterial inosine-5 -monophosphate dehydrogenase. Biochemis-
Juvale, K., Stefan, K., & Wiese, M. (2013). Synthesis and biological evalua-
tion of flavones and benzoflavones as inhibitors of BCRP/ABCG2.
European Journal of Medicinal Chemistry, 67, 115–126.
try, 38(15), 4691–4700.
Maurya, S. K., Gollapalli, D. R., Kirubakaran, S., Zhang, M., Johnson, C. R.,
Benjamin, N. N., … Cuny, G. D. (2009). Triazole inhibitors of Cryptospo-
SUPPORTING INFORMATION
0
Additional supporting information may be found online in the Sup-
porting Information section at the end of the article.
ridium parvum inosine 5 - monophosphate dehydrogenase. Journal of
Medicinal Chemistry, 52(15), 4623–4630.
Moss, S. F. (2017). The clinical evidence linking Helicobacter pylori to gas-
tric cancer. Cellular and Molecular Gastroenterology and Hepatology,
3
(2), 183–191.
How to cite this article: Sahu NU, Purushothaman G,
Petrelli, R., Vita, P., Torquati, I., Felczak, K., Wilson, D. J., Franchetti, P., &
Cappellacci, L. (2013). Novel inhibitors of inosine monophosphate
dehydrogenase in patent literature of the last decade. Recent Patents
on Anti-Cancer Drug Discovery, 8(2), 103–125.
Thiruvenkatam V, Kharkar PS. Design, synthesis, and biological
0
evaluation of Helicobacter pylori inosine 5 -monophosphate
Sahu, N. U., & Kharkar, P. S. (2016). Computational drug repositioning: A
lateral approach to traditional drug discovery? Current Topics in Medici-
nal Chemistry, 16(19), 2069–2077.
1